All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2012-005287-10 | A Phase III Double-blinded, Placebo Controlled Study of Xilonix? for Improving Survival in Metastatic Colorectal Cancer Estudio de fase III, doble ciego, controlado con placebo de Xilonix? para la... | 2017-07-07 | due-trials |
Reported results | 2014-000550-12 | A Double Blind, Placebo Controlled, Pivotal Phase III Study Evaluating Xilonix™ in Symptomatic Colorectal Cancer Patients Refractory To Standard Therapy | 2017-10-12 | due-trials |
Exempt | 2015-003510-25 | A Phase I-II Study of the Safety and Efficacy of a True Human Antibody, 514G3, in Subjects Hospitalized with Bacteremia Due to Staphylococcus Aureus Eine Phase-I-II-Studie über die Sicherheit und ... | 2017-03-27 | not-yet-due |